Model-based estimation of the generalized impact fraction (GIF) and population attributable fraction (PAF) for interventions targeting risk factors affecting the five-year risk of diabetic retinopathy

基于模型的干预措施对影响糖尿病视网膜病变五年风险的危险因素的广义影响分数 (GIF) 和人群归因分数 (PAF) 进行估计

阅读:2

Abstract

BACKGROUND: Diabetic Retinopathy (DR) is a microvascular complication of diabetes mellitus. Health policymakers are interested in studying the impact of interventions on reducing new cases of DR. The study aimed to calculate the generalized impact fraction (GIF) and population attributable fraction (PAF) of interventions targeting three risk factors on the five-year risk of DR. METHODS: A retrospective cohort study was conducted among 1,742 patients with diabetes who completed their baseline assessment between 2015 and 2017. Follow-up studies were carried out during visits from 2020 to 2022, aiming to determine the five-year risk of DR. To estimate the PAF and GIF in different scenarios, a parametric G. formula was utilized. RESULTS: In this study, all patients had type 2 diabetes, and the five-year risk of developing diabetic retinopathy (DR) was 16.1% (95% CI: 14.4-18.0). Lowering HbA1c to below 7% would be expected to prevent 35.07% (95% CI: 34.7-36.2) of DR cases. A reduction of 30% in patients with HbA1c levels above 7% corresponds to a GIF of 10.3% (95% CI: 9.9-10.7). Similarly, normalizing blood pressure levels resulted in a PAF of 22.1% (95% CI: 21.8-22.6). A 25% decrease in prevalence above 130/80 mmHg was associated with a GIF for DR of 5.3% (95% CI: 5.1-5.4). Reducing LDL cholesterol levels to less than 100 mg/dl had a lower impact, with a PAF of 1.9% (95% CI: 1.3-2.3). A 20% reduction in prevalence above this level corresponded to a GIF of 0.3% (95% CI: 0.2-0.5). CONCLUSION: Reducing HbA1c and blood pressure by 20-30% would be expected to prevent the five-year risk of DR by 15.5% (95% CI: 15.3-15.9). These levels of decrease are achievable and conceivable to policymakers, which can encourage them to implement a program. This could be a Policy-making approach to prevent DR.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。